Cargando…
A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
BACKGROUND: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. METHODS AND FINDINGS: We measured plasma phospholipid fatty acids by gas chrom...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636062/ https://www.ncbi.nlm.nih.gov/pubmed/29020051 http://dx.doi.org/10.1371/journal.pmed.1002409 |
_version_ | 1783270375361085440 |
---|---|
author | Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Kröger, Janine Griffin, Julian L. Huerta, José M. Guevara, Marcela Sluijs, Ivonne Agudo, Antonio Ardanaz, Eva Balkau, Beverley Boeing, Heiner Chajes, Veronique Dahm, Christina C. Dow, Courtney Fagherazzi, Guy Feskens, Edith J. M. Franks, Paul W. Gavrila, Diana Gunter, Marc Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Melander, Olle Molina-Portillo, Elena Nilsson, Peter M. Olsen, Anja Overvad, Kim Palli, Domenico Panico, Salvatore Rolandsson, Olov Sieri, Sabina Sacerdote, Carlotta Slimani, Nadia Spijkerman, Annemieke M. W. Tjønneland, Anne Tumino, Rosario van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Forouhi, Nita G. Wareham, Nick J. |
author_facet | Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Kröger, Janine Griffin, Julian L. Huerta, José M. Guevara, Marcela Sluijs, Ivonne Agudo, Antonio Ardanaz, Eva Balkau, Beverley Boeing, Heiner Chajes, Veronique Dahm, Christina C. Dow, Courtney Fagherazzi, Guy Feskens, Edith J. M. Franks, Paul W. Gavrila, Diana Gunter, Marc Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Melander, Olle Molina-Portillo, Elena Nilsson, Peter M. Olsen, Anja Overvad, Kim Palli, Domenico Panico, Salvatore Rolandsson, Olov Sieri, Sabina Sacerdote, Carlotta Slimani, Nadia Spijkerman, Annemieke M. W. Tjønneland, Anne Tumino, Rosario van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Forouhi, Nita G. Wareham, Nick J. |
author_sort | Imamura, Fumiaki |
collection | PubMed |
description | BACKGROUND: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. METHODS AND FINDINGS: We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991–1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested case-cohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of γ-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19–0.29) adjusted for potential confounders and 0.37 (95% CI 0.27–0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. CONCLUSIONS: A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors. |
format | Online Article Text |
id | pubmed-5636062 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-56360622017-10-30 A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Kröger, Janine Griffin, Julian L. Huerta, José M. Guevara, Marcela Sluijs, Ivonne Agudo, Antonio Ardanaz, Eva Balkau, Beverley Boeing, Heiner Chajes, Veronique Dahm, Christina C. Dow, Courtney Fagherazzi, Guy Feskens, Edith J. M. Franks, Paul W. Gavrila, Diana Gunter, Marc Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Melander, Olle Molina-Portillo, Elena Nilsson, Peter M. Olsen, Anja Overvad, Kim Palli, Domenico Panico, Salvatore Rolandsson, Olov Sieri, Sabina Sacerdote, Carlotta Slimani, Nadia Spijkerman, Annemieke M. W. Tjønneland, Anne Tumino, Rosario van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Forouhi, Nita G. Wareham, Nick J. PLoS Med Research Article BACKGROUND: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. METHODS AND FINDINGS: We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991–1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested case-cohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of γ-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19–0.29) adjusted for potential confounders and 0.37 (95% CI 0.27–0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. CONCLUSIONS: A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors. Public Library of Science 2017-10-11 /pmc/articles/PMC5636062/ /pubmed/29020051 http://dx.doi.org/10.1371/journal.pmed.1002409 Text en © 2017 Imamura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Kröger, Janine Griffin, Julian L. Huerta, José M. Guevara, Marcela Sluijs, Ivonne Agudo, Antonio Ardanaz, Eva Balkau, Beverley Boeing, Heiner Chajes, Veronique Dahm, Christina C. Dow, Courtney Fagherazzi, Guy Feskens, Edith J. M. Franks, Paul W. Gavrila, Diana Gunter, Marc Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Melander, Olle Molina-Portillo, Elena Nilsson, Peter M. Olsen, Anja Overvad, Kim Palli, Domenico Panico, Salvatore Rolandsson, Olov Sieri, Sabina Sacerdote, Carlotta Slimani, Nadia Spijkerman, Annemieke M. W. Tjønneland, Anne Tumino, Rosario van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Forouhi, Nita G. Wareham, Nick J. A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study |
title | A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study |
title_full | A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study |
title_fullStr | A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study |
title_full_unstemmed | A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study |
title_short | A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study |
title_sort | combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: the epic-interact case-cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636062/ https://www.ncbi.nlm.nih.gov/pubmed/29020051 http://dx.doi.org/10.1371/journal.pmed.1002409 |
work_keys_str_mv | AT imamurafumiaki acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sharpstephenj acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT koulmanalbert acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT schulzematthiasb acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT krogerjanine acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT griffinjulianl acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT huertajosem acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT guevaramarcela acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sluijsivonne acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT agudoantonio acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT ardanazeva acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT balkaubeverley acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT boeingheiner acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT chajesveronique acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT dahmchristinac acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT dowcourtney acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT fagherazziguy acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT feskensedithjm acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT frankspaulw acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT gavriladiana acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT guntermarc acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT kaaksrudolf acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT keytimothyj acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT khawkaytee acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT kuhntilman acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT melanderolle acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT molinaportilloelena acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT nilssonpeterm acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT olsenanja acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT overvadkim acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT pallidomenico acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT panicosalvatore acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT rolandssonolov acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sierisabina acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sacerdotecarlotta acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT slimaninadia acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT spijkermanannemiekemw acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT tjønnelandanne acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT tuminorosario acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT vanderschouwyvonnet acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT langenbergclaudia acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT ribolielio acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT forouhinitag acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT warehamnickj acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT imamurafumiaki combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sharpstephenj combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT koulmanalbert combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT schulzematthiasb combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT krogerjanine combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT griffinjulianl combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT huertajosem combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT guevaramarcela combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sluijsivonne combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT agudoantonio combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT ardanazeva combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT balkaubeverley combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT boeingheiner combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT chajesveronique combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT dahmchristinac combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT dowcourtney combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT fagherazziguy combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT feskensedithjm combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT frankspaulw combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT gavriladiana combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT guntermarc combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT kaaksrudolf combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT keytimothyj combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT khawkaytee combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT kuhntilman combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT melanderolle combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT molinaportilloelena combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT nilssonpeterm combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT olsenanja combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT overvadkim combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT pallidomenico combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT panicosalvatore combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT rolandssonolov combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sierisabina combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT sacerdotecarlotta combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT slimaninadia combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT spijkermanannemiekemw combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT tjønnelandanne combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT tuminorosario combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT vanderschouwyvonnet combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT langenbergclaudia combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT ribolielio combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT forouhinitag combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy AT warehamnickj combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy |